Interestingly, it has been reported that variant isoforms of CD44 containing v8-v10 (CD44v8-10) regulate redox status in cancer cells by stabilizing SLC7A11 and promoting tumor growth, metastasis, and cisplatin resistance [113,114,115,116]. This evidence concerns the gene CD44 and neoplasm.